- Published at
- by manilatimes.net
neutral
neutral
News for Silo Pharma Inc. (SILO)
- Published at
- by gurufocus.com
neutralneutralSiloPharma (SILO) Advances SPC-15 with New Drug-Device Study Agreement | SILO Stock News
SiloPharma, under the ticker SILO, has secured a service agreement with Resyca BV, a medical technology firm, to explore the application of a novel microchip-ba- Published at
- by manilatimes.net
negativenegative- Published at
- by manilatimes.net
neutralneutral- Published at
- by gurufocus.com
neutralneutralSilo Pharma Announces Pricing of $2 Million Public Offering
SARASOTA, FL, May 15, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. ( SILO) (”Silo” or the ”Company”), a developmental stage biopharmaceutical company fo- Published at
- by gurufocus.com
neutralneutralSiloPharma (SILO) Sets $2 Million Public Offering with Warrants | SILO Stock News
SiloPharma, with ticker SILO, has announced a public offering involving 3,333,338 shares of common stock. Accompanying these shares are series A-1 and A-2 warra- Published at
- by gurufocus.com
positivepositiveSilo Pharma Announces Pricing of $2 Million Public Offering | SILO Stock News
Silo Pharma (SILO) announces a $2 million public offering priced at $0.60 per share. The offering includes 3,333,338 shares and Series A-1 and A-2 warra- Published at
- by gurufocus.com
positivepositiveSilo Pharma (SILO) Advances PTSD Treatment with New Study Agreement | SILO Stock News
Silo Pharma (SILO) has initiated a collaboration with Frontage Laboratories to conduct a 7-day safety and toxicology study on its primary asset, SPC-15, as requ- Published at
- by gurufocus.com
positivepositiveSilo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories | SILO Stock News
Silo Pharma (SILO) advances PTSD drug SPC-15 with key safety study. IND submission targeted for 2025, with Phase 1 clinical trials pending approval. SPC-15- Published at
- by gurufocus.com
neutralneutralSilo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories
Clear Regulatory Path to Clinical Trials for Intranasal PTSD Therapy Targeting Multi-Billion-Dollar Market SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Si- Published at
- by manilatimes.net
neutralneutral- Published at
- by gurufocus.com
positivepositiveSILO Pharma Achieves Milestone with Promising Preclinical Results for SP-26 | SILO Stock News
Silo Pharma (SILO) reported encouraging outcomes from its preclinical trial focused on SP-26, an innovative extended-release ketamine implant. The study indicat- Published at
- by gurufocus.com
positivepositiveSilo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study | SILO Stock News
SP-26 ketamine implant by Silo Pharma (SILO) met all preclinical study endpoints. Sustained drug release of up to 22 days achieved post-implantation.- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveSilo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug | SILO Stock News
Silo Pharma files patent for SPC-14, an Alzheimer's treatment. SPC-14 targets glutamate receptor NDMAR and serotonin 5-HT4. Early pre-clinical studie- Published at
- by gurufocus.com
neutralneutralSilo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment
SARASOTA, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. ( SILO) (”Silo” or the ”Company”), a developmental stage biopharmaceutical company- Published at
- by manilatimes.net
neutralneutral- Published at
- by gurufocus.com
neutralneutralSilo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment
SPC-15 combination treatment shows enhanced efficacy in combating stress-induced psychiatric disorders SARASOTA, FL, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Silo- Published at
- by manilatimes.net
negativenegative- Published at
- by benzinga.com
mixedmixedWhy Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket - Aviat Networks (NASDAQ:AVNW), Bridger Aerospace Gr (NASDAQ:BAER)
Shares of Zoomcar Holdings Inc ZCAR rose sharply in today's pre-market trading after the company announced a significant achievement in its financial performanc...